MERCIER JOHANNA (Chief Commercial Officer) sold 18.2% of their position (28K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $3.68M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+25K
Price / share
$66.64
Trade value
$1.67M
% of position
Common Stock
Shares
−7.75K
Price / share
$130.29
Trade value
$1.01M
% of position
Common Stock
Shares
−11.18K
Price / share
$131.19
Trade value
$1.47M
% of position
Common Stock
Shares
−8.37K
Price / share
$132.23
Trade value
$1.11M
% of position
Common Stock
Shares
−700.00
Price / share
$132.75
Trade value
$92.93K
% of position
Net shares
−3K
Net value
-$2.01M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | M · Option Exercise | +25K | $66.64 | $1.67M | 19.4% | 128.78K | 153.78K |
| Common Stock Direct | 5/15/2026 | S · Sale | −7.75K | $130.29 | $1.01M | 5.0% | 153.78K | 146.03K |
| Common Stock Direct | 5/15/2026 | S · Sale | −11.18K | $131.19 | $1.47M | 7.7% | 146.03K | 134.85K |
| Common Stock Direct | 5/15/2026 | S · Sale | −8.37K | $132.23 | $1.11M | 6.2% | 134.85K | 126.48K |
| Common Stock Direct | 5/15/2026 | S · Sale | −700.00 | $132.75 | $92.93K | 0.6% | 126.48K | 125.78K |
| Total | −3K | -$2.01M | ||||||
Non-qualified Stock Option (Right to Buy)
Common Stock
25K shares
Shares
−25K
Strike price
66.64
Held after
23.11K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy) Direct | Common Stock25K shares | 5/15/2026 | M · Option Exercise | −25K | 66.64 | — | 23.11K |